Skip to main content

Table 9 Perioperative and long-term outcome after pancreatic resection for intraductal papillary mucinous neoplasm (IPMN)

From: Pancreatic resection for intraductal papillary mucinous neoplasm– a thirteen-year single center experience

Series

number of patients

non-invasive IPMNa (n/%)

Invasive IPMNa (n/%)

Perioperative mortality (n/%)

Perioperative morbidity (Clavien Dindo/others; n(%))

Survival

Recurrence rate

Comment

Salvia et al. [44]

n = 140

47 (34 %)

83 (66 %)

0

33 (24 %)(major complication)

10-year overall survival non-invasive IPMNa 100 %; invasive IPMNa: 50 %.

n.s.b

 

Sohn et al. [14]

n = 136

84 (62 %)

52 (38 %)

5 (3.7 %)

47 (35 %)

5-year overall survival non-invasive IPMNa :77 %; invasive. IPMNa: 43 %.

n.s.b

 

D'Angelica et al. [15]

n = 62 a

33a (52 %)

30 (48 %)

4 (6 %)

31 (50 %)

5-year-overall survival:75 %/10 year-overall survival:60 %

23 %

a 1 patient Unresectable

Rodriguez et al. [39]

n = 145

113 (78 %)

32 (22 %)

0

86 (59 %)

10-year-overall survival: 70 %, invasive Carcinoma : 10-year-overall survival: 63 %

6.9 %

only branch duct-IPMNa

Niedergethmann [20]

n = 97

29 (30 %)

68 (70 %)

1 (1 %)

55 (56.7 %)

median overall survival: 36 months

n.s.b

 

Sahora et al. [35]

n = 226

174 (77 %)

52 (23 %)

1.3 %

34 %

n.s.

8.5 %

only branch-duct-IPMNa

Marchegiani et al. [21]

n = 173

48 (28 %)

125 (72 %)

0

15.6 % ("major surgical complications")

10 year-overall survival: 69 %

25 %

only main-duct-IPMNa

present series

n = 54

24 (44 %)

30 (56 %)

2 (3.7 %)

20 (37 %)

5-year-overall survival non-invasive IPMNa: 100 %, invasive IPMNa 69 %

6 (12 %)

 
  1. aIPMN intraductal papillary mucinous neoplasm
  2. bn.s. not specified